Imatinib might constitute a treatment option for lung involvement in COVID-19

被引:24
作者
Bernal-Bello, David [1 ]
Jaenes-Barrios, Beatriz [2 ]
Morales-Ortega, Alejandro [1 ]
Manuel Ruiz-Giardin, Jose [1 ]
Garcia-Bermudez, Virginia [1 ]
Frutos-Perez, Begona [1 ]
Isabel Farfan-Sedano, Ana [1 ]
de Ancos-Aracil, Cristina [1 ]
Bermejo, Fernando [3 ]
Garcia-Gil, Mario [4 ]
Zapatero-Gaviria, Antonio [1 ]
Victor San Martin-Lopez, Juan [1 ]
机构
[1] Hosp Univ Fuenlabrada, Dept Internal Med, Camino Molino 2, Madrid 28942, Spain
[2] Castilla La Nueva Primary Hlth Care Ctr, Madrid, Spain
[3] Hosp Univ Fuenlabrada, Inst Invest Sanitaria Hosp La Paz IdiPaz, Dept Gastroenterol, Madrid, Spain
[4] Hosp Univ Fuenlabrada, Dept Hosp Pharm, Madrid, Spain
关键词
KINASE INHIBITORS; MESYLATE; REMISSION; PATIENT; ABL;
D O I
10.1016/j.autrev.2020.102565
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页数:2
相关论文
共 35 条
[31]   European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia [J].
Steegmann, J. L. ;
Baccarani, M. ;
Breccia, M. ;
Casado, L. F. ;
Garcia-Gutierrez, V. ;
Hochhaus, A. ;
Kim, D-W ;
Kim, T. D. ;
Khoury, H. J. ;
Le Coutre, P. ;
Mayer, J. ;
Milojkovic, D. ;
Porkka, K. ;
Rea, D. ;
Rosti, G. ;
Saussele, S. ;
Hehlmann, R. ;
Clark, R. E. .
LEUKEMIA, 2016, 30 (08) :1648-1671
[32]   The tyrosine kinase inhibitor imatinib prevents lung injury and death after intravenous LPS in mice [J].
Stephens, R. Scott ;
Johnston, Laura ;
Servinsky, Laura ;
Kim, Bo S. ;
Damarla, Mahendra .
PHYSIOLOGICAL REPORTS, 2015, 3 (11)
[33]   Resolution of Rheumatoid Arthritis Symptoms With Imatinib Mesylate [J].
Vernon, Matthew R. ;
Pearson, Larry ;
Atallah, Ehab .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2009, 15 (05) :267-267
[34]   A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option [J].
Yao, Tian-Tian ;
Qian, Jian-Dan ;
Zhu, Wen-Yan ;
Wang, Yan ;
Wang, Gui-Qiang .
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (06) :556-563
[35]   In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) [J].
Yao, Xueting ;
Ye, Fei ;
Zhang, Miao ;
Cui, Cheng ;
Huang, Baoying ;
Niu, Peihua ;
Liu, Xu ;
Zhao, Li ;
Dong, Erdan ;
Song, Chunli ;
Zhan, Siyan ;
Lu, Roujian ;
Li, Haiyan ;
Tan, Wenjie ;
Liu, Dongyang .
CLINICAL INFECTIOUS DISEASES, 2020, 71 (15) :732-739